Vascular Closure Systems, Inc. Announces 30-Day Follow-Up Results for Phase I of the First in Human (FIH) Clinical Use, of the FastSeal® Bioabsorbable Vascular Access Closure System
6/29/2012 9:45:00 AM
More...
|
Vascular Closure Systems, Inc. Announces Conclusion of Phase I of the First in Human (FIH) Use of the FastSeal® Bioabsorbable Vascular Access Closure System
5/8/2012 10:11:12 AM
More...
|
Vascular Closure Systems, Inc. Announces Invitation to Attend One of Our Upcoming Pre-Clinical Studies / Company Expects to Receive a Notice of Allowance for an Unpublished Patent Application in the Near Future
8/25/2009 8:59:38 AM
More...
|